Status:
COMPLETED
Remifentanil Dosing Regimes for Anesthesia in Bariatric Surgery: Characteristics of Early Recovery
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Morbid Obesity
Eligibility:
All Genders
28-57 years
Brief Summary
Early recovery characteristics are important for patients' safety and operating room turnover. Our aim was to compare fundamental methods for dosing remifentanil during morbid obesity surgeries: a man...
Detailed Description
Introduction: The population of overweighted patients is increasing dramatically, therefore physicians face them in their daily practice (1-2). There are many guidelines showing the dose counting meth...
Eligibility Criteria
Inclusion
- Morbid patients to whom, according guidelines (BMI \> 45 or BMI \> 35 and chronic disease) bariatric surgery is indicated.
- Patient's approval.
Exclusion
- Patients, younger than 18 years old.
- Patients who are higher than III ASA class.
- Patients who have higher sensibility to medications that are used during anesthesia.
- Patients with phycological disorders.
- Patients who can not fully communicate because of language barriers.
- Patients with surgical complications.
- Patient's disapproval.
Key Trial Info
Start Date :
October 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2020
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04690088
Start Date
October 10 2019
End Date
February 10 2020
Last Update
December 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lithuanian University of Health Sciences
Kaunas, Lithuania